However, a comparison of lymphocyte subpopulations in NSCLC patients with different histology revealed elevated percentages of CD69+/CD94+ NK cells in squamous cell but not adeno NSCLC patients. This evidence concerns the gene CD69 and non-small cell lung carcinoma.